We have shown that the majority of IL-22-producing cells at the site of allergic airway inflammation are CD4+ T cells and that one third of the IL-22-producing CD4+ T cells produce IL-17A [22], suggesting that some of IL-22-producing CD4+ T cells in a murine asthma model are Th17 cells. This evidence concerns the gene IL22 and asthma.